Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression
Open Access
- 14 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 846917
Abstract
Cancer is primarily a disease of dysregulation – both at the genetic level and at the tissue organization level. One way that tissue organization is dysregulated is by changes in the bioelectric regulation of cell signaling pathways. At the basis of bioelectricity lies the cellular membrane potential or Vmem, an intrinsic property associated with any cell. The bioelectric state of cancer cells is different from that of healthy cells, causing a disruption in the cellular signaling pathways. This disruption or dysregulation affects all three processes of carcinogenesis – initiation, promotion, and progression. Another mechanism that facilitates the homeostasis of cell signaling pathways is the production of extracellular vesicles (EVs) by cells. EVs also play a role in carcinogenesis by mediating cellular communication within the tumor microenvironment (TME). Furthermore, the production and release of EVs is altered in cancer. To this end, the change in cell electrical state and in EV production are responsible for the bioelectric dysregulation which occurs during cancer. This paper reviews the bioelectric dysregulation associated with carcinogenesis, including the TME and metastasis. We also look at the major ion channels associated with cancer and current technologies and tools used to detect and manipulate bioelectric properties of cells.Keywords
Funding Information
- National Science Foundation
This publication has 181 references indexed in Scilit:
- Molecular bioelectricity in developmental biology: New tools and recent discoveriesBioEssays, 2012
- Genetically Encoding Unnatural Amino Acids in Neural Stem Cells and Optically Reporting Voltage-Sensitive Domain Changes in Differentiated NeuronsStem Cells, 2011
- Imaging Intracellular pH in Live Cells with a Genetically Encoded Red Fluorescent Protein SensorJournal of the American Chemical Society, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cell Shape and Substrate Rigidity Both Regulate Cell StiffnessBiophysical Journal, 2011
- Bioelectric mechanisms in regeneration: Unique aspects and future perspectivesSeminars in Cell & Developmental Biology, 2009
- Substrate rigidity regulates Ca2+ oscillation via RhoA pathway in stem cellsJournal of Cellular Physiology, 2008
- Theories of carcinogenesis: An emerging perspectiveSeminars in Cancer Biology, 2008
- Genetically encoded fluorescent sensors of membrane potentialBrain Cell Biology, 2008
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007